Letong shares: the CSRC resumes the examination of the application for major asset restructuring
Cailian news agency, Dec. 1, Letong announced that the company had received the notice on resumption of examination of administrative license application issued by the CSRC, and the CSRC decided to resume the examination of the company's reorganization in accordance with relevant regulations.
This text is a result of machine translation.
Briefing Dec 19, 2023 10:56 AM
EcoFlow Fined 100 Million Euros from EU, Sources Say
In-depth
Briefing Oct 20, 2023 06:03 PM
· Technology
China’s OpenAI Challenger Zhipu AI Secures Over CNY 2.5 Billion to Step Further on Large-Scale Model
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
May 11, 2023 05:07 PM
Jan 06, 2023 08:30 AM
Briefing Oct 18, 2023 07:02 PM
UAE Bets Big on Renewable Energy, Expects to Invest Over USD 160 Billion in Next 30 Years
Briefing Oct 18, 2023 07:01 PM
Wind Power is Propelled into a New Phase of Extraordinary Growth
Briefing Oct 08, 2023 06:27 PM
Shenzhen Sets Ambitious Goals for Green and Innovative Industries: Aiming for CNY 100 Billion in New Energy Industry Value
Briefing Oct 08, 2023 06:20 PM
Shenzhen Targets 1 Million Kilowatts of Virtual Power Plant Load Regulation by 2025
Briefing Oct 08, 2023 06:15 PM
Shenzhen Accelerates Drive Towards Green Construction: Over 100 Projects to Join Smart Construction Pilot by 2025
Briefing Sep 26, 2023 06:28 PM
SPIC Smart Energy Corporation and Tencent Cloud Officially Signs a Strategic Cooperation Agreement
Briefing Sep 26, 2023 06:27 PM
SVOLT is Poised to Ship 1.6 Million Units Domestically this Year
Technology
AI Technology Provider RealAI Completes New Round of Strategic Financing
According to EqualOcean, recently, AI security infrastructure provider RealAI(瑞莱智慧) announced the completion of a new round of strategic financing, with investors including the Beijing Artificial Intelligence Industry Investment Fund(北京市人工智能产业投资基金).
Updated 2 hours ago
Healthcare
Cellatopia Secures Nearly CNY Ten Mn in Seed Funding
EqualOcean has learned that Cellatopia(喜同生物), a biotechnology company based in Suzhou, recently announced the successful securing of nearly CNY ten million in seed funding. The funding was primarily led by Suzhou Shishangbai Venture Capital(苏州石上柏创业合伙企业) and followed by institutions such as Suzhou Nuowei Venture Investment Limited(苏州诺为创业投资有限公司).
Updated 2 hours ago
Briefing Sep 20, 2023 12:51 PM
Chinese Insurtech QingSong Health Marks 9th Anniversary with Bold Steps Towards a Healthier China
Briefing Sep 18, 2023 07:40 PM
· Technology
4Paradigm Initiates IPO Today and Targets HKSE on September 28
Briefing Sep 18, 2023 07:38 PM
· Automotive
Electric Vehicles to Account for Two-thirds of Global Vehicle Sales by 2030
See more
Read next
Insight
In-depth
Insight
In-depth